Video Shares Investor Evening12 Nov 2015 10:36
Biofrontera (B8F) - Shares Investor Evening
Shares Magazine
Published on Nov 12, 2015
Biofrontera (B8F)
https://www.youtube.com/watch?v=zM29P5d2J9I
We specialize in dermatology, because the health of your skin is our profession.
With our innovative products we would like to cure and protect your skin, while
creating value for our investors.
Biofrontera AG operates as an administrative holding company with four wholly-owned subsidiaries, Biofrontera Bioscience GmbH, Biofrontera Pharma GmbH, Biofrontera Development GmbH and Biofrontera Neuroscience GmbH. While the first two cover the operational business of Biofrontera group, the latter allow structured funding of individual clinical development projects. The companies occupy fully equipped, modern lab facilities with sufficient space for growth, an own GMP-certified laboratory and a GMP-certified medicament storage room.
Biofrontera group was founded in 1997 by Prof. Dr. Hermann Lübbert, the current CEO, and is located in Leverkusen, Germany.
Since 2006 Biofrontera is listed in the regulatory market under the ISIN DE0006046113, the company currently employs 46 people.